# BLOXIVERZ
> **NDA204078** · New Drug Application · Sponsor: EXELA PHARMA · Approved 2013-05-31
## Drug
- **FDA Application Number:** NDA204078
- **Application type:** New Drug Application
- **Brand name:** BLOXIVERZ
- **Generic name:** NEOSTIGMINE METHYLSULFATE
- **Active ingredients:** NEOSTIGMINE METHYLSULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** EXELA PHARMA
- **Manufacturer:** Exela Pharma Sciences, LLC
- **First approval:** 2013-05-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204078)
---
*AI Analytics · CC0 1.0*